Taribavirin hydrochloride

Overview

Taribavirin hydrochloride is an orally active inosine monophosphate dehydrogenase inhibitor, has activity against a wide range of viruses, especially the hepatitis C virus and influenza virus . Taribavirin hydrochloride is a Ribavirin proagent, is designed to concentrate within the liver to target HCV-infected hepatocytes while minimizing distribution within red blood cells (RBCs) and the development of hemolytic anemia.

Application

Products | Products > Disease Areas > Viral Infection | Products > Disease Areas > Blood Disease | Products > Disease Areas > Hepatitis C Virus Infection | Products > Disease Areas > Lung Fibrosis | Products > Disease Areas > Infection | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Hepatitis Virus Infection | Products > Disease Areas > Pulmonary Disease | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > HBV | Products > Signaling Pathways > HCV

Product Information

• Catalog No.: HY-10545A
• CAS No.: 40372-00-7
• Molecular Formula: C8H14ClN5O4
• Molecular Weight: 279.68
• Purity: 99.89%
• Storage: 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Availability: In-stock

Source

Original product source